First Time Loading...
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 49.6 PLN -2.17% Market Closed
Updated: Jul 27, 2024
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Wall Street
Price Targets

RVU Price Targets Summary
Ryvu Therapeutics SA

Wall Street analysts forecast RVU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVU is 84.25 PLN with a low forecast of 69.19 PLN and a high forecast of 104.27 PLN.

Lowest
Price Target
69.19 PLN
39% Upside
Average
Price Target
84.25 PLN
70% Upside
Highest
Price Target
104.27 PLN
110% Upside
Ryvu Therapeutics SA Competitors:
Price Targets
IQV
IQVIA Holdings Inc
18% Upside
4133
Abnova Taiwan Corp
214% Upside
ILMN
Illumina Inc
20% Upside
QGEN
Qiagen NV
16% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
27% Upside
CRL
Charles River Laboratories International Inc
12% Upside
MTD
Mettler-Toledo International Inc
3% Downside
038290
Macrogen Inc
78% Upside

Revenue
Forecast

Revenue Estimate
Ryvu Therapeutics SA

For the last 8 years the compound annual growth rate for Ryvu Therapeutics SA's revenue is 2%. The projected CAGR for the next 2 years is 141%.

2%
Past Growth
141%
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ryvu Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Ryvu Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RVU's stock price target?
Price Target
84.25 PLN

According to Wall Street analysts, the average 1-year price target for RVU is 84.25 PLN with a low forecast of 69.19 PLN and a high forecast of 104.27 PLN.

What is Ryvu Therapeutics SA's Revenue forecast?
Projected CAGR
141%

For the last 8 years the compound annual growth rate for Ryvu Therapeutics SA's revenue is 2%. The projected CAGR for the next 2 years is 141%.